ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,812,620 | -37.8% | 71,363 | -0.7% | 0.02% | -38.5% |
| Q4 2022 | $2,913,546 | +52.5% | 71,833 | +24.2% | 0.03% | +44.4% |
| Q3 2022 | $1,911,000 | -13.5% | 57,826 | -7.8% | 0.02% | -14.3% |
| Q2 2022 | $2,209,000 | -60.7% | 62,730 | -51.9% | 0.02% | -74.7% |
| Q3 2020 | $5,617,000 | -6.3% | 130,451 | -6.0% | 0.08% | +3.8% |
| Q2 2020 | $5,997,000 | +698.5% | 138,841 | +1072.3% | 0.08% | +1233.3% |
| Q4 2019 | $751,000 | +115.8% | 11,843 | -4.2% | 0.01% | +100.0% |
| Q3 2019 | $348,000 | -58.5% | 12,357 | -89.4% | 0.00% | -57.1% |
| Q1 2018 | $839,000 | +175.1% | 116,402 | +40.5% | 0.01% | +250.0% |
| Q4 2017 | $305,000 | – | 82,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |